Marketing News

Philips sells VCSEL subsidiary , completes acquisition in the second quarter of next year


According to media reports, a few days ago, Philips agreed to sell its growing VCSEL business - Philips Photonics, a German established company called Trumpf is acquiring 100% of its shares.

Philips Photonics, based in Ulm, Germany, is a wholly-owned subsidiary of Royal Philips, which provides vertical cavity surface emitting laser (VCSEL) technology for datacom, consumer and industrial applications. Applications such as smartphones, digital data transmission, and autopilot sensors. The company currently has approximately 280 employees. Philips entered VCSELs in 2006 through the acquisition of Ulm Photonics in Germany and renamed it Philips Photonics.

The acquisition was made after Philips announced the third time in three years to expand the factory for vertical cavity surface emitting laser (VCSEL) in Ulm, Germany. Not long ago, Philips Photonics is proud to announce that it has reached a milestone of over one billion VCSEL shipments. The company has begun to sell VCSELs to smartphone manufacturers in bulk, which smartphone manufacturers can use to unlock their phones. Identify functions such as the system.

Trumpf is a veteran family-owned company based in Stuttgart, Germany, with a revenue of 3.56 billion euros last year. It produces machine tools, laser precision cutting equipment and lasers, and is a global machine tool and laser technology giant. The acquisition of Philips Photonics will help it expand VCSELs, which compete with LEDs in certain applications, such as facial recognition, and are expanding into a variety of applications, including laser radar guidance for unmanned vehicles, medical imaging, and fiber optic data transmission. Wait.

“With this acquisition, we hope to open up new product areas and expand our existing product portfolio with strategic focus,” said Trumpf CEO Nicola Leibinger-Kammüller.

The two companies have not disclosed the agreed price, the acquisition is subject to regulatory approval, and Philips and Trumpf hope to complete in the second quarter of 2019.

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept